• Home
  • Study Details
By physician referral or invitation only

PSMA-PET/MRI Low and Intermediate-Risk Target Volume Pilot Study

This is a pilot trial testing the safety and feasibility of using PSMA-PET and mpMRI to optimize radiotherapy targets for patients with low-risk or intermediate-risk prostate cancer.

Age & Gender

  • 18 years ~ 99 years
  • Male

Contact the Team


Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Michael Repka
Radiation Oncology - Chapel Hill

Study Type

Clinical or Medical

Study Topics

Cancer (Prostate)

IRB Number


Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.


  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research